Selected Financial Data
since 2005
Income Statement
UnitedHealth Group Inc., selected items from income statement, long-term trends
US$ in millions
| 12 months ended: | Revenues, customers | Earnings from operations | Net earnings attributable to UnitedHealth Group common shareholders |
|---|---|---|---|
| Dec 31, 2024 | 395,076) | 32,287) | 14,405) |
| Dec 31, 2023 | 367,533) | 32,358) | 22,381) |
| Dec 31, 2022 | 322,132) | 28,435) | 20,120) |
| Dec 31, 2021 | 285,273) | 23,970) | 17,285) |
| Dec 31, 2020 | 255,639) | 22,405) | 15,403) |
| Dec 31, 2019 | 240,269) | 19,685) | 13,839) |
| Dec 31, 2018 | 224,871) | 17,344) | 11,986) |
| Dec 31, 2017 | 200,136) | 15,209) | 10,558) |
| Dec 31, 2016 | 184,012) | 12,930) | 7,017) |
| Dec 31, 2015 | 156,397) | 11,021) | 5,813) |
| Dec 31, 2014 | 129,695) | 10,274) | 5,619) |
| Dec 31, 2013 | 121,744) | 9,623) | 5,625) |
| Dec 31, 2012 | 109,938) | 9,254) | 5,526) |
| Dec 31, 2011 | 101,208) | 8,464) | 5,142) |
| Dec 31, 2010 | 93,546) | 7,864) | 4,634) |
| Dec 31, 2009 | 86,546) | 6,359) | 3,822) |
| Dec 31, 2008 | 80,415) | 5,263) | 2,977) |
| Dec 31, 2007 | 74,287) | 7,849) | 4,654) |
| Dec 31, 2006 | 70,671) | 6,984) | 4,159) |
| Dec 31, 2005 | 44,866) | 5,373) | 3,300) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
- Revenues (US$ in millions)
- Revenues show a consistent upward trend from 2005 through 2024, increasing from approximately $44.9 billion to nearly $395.1 billion. The growth is steady with no years of decline, indicating sustained expansion in customer base or service offerings. The most notable acceleration occurs post-2015, with revenues increasing significantly from around $156 billion to over $395 billion in less than a decade.
- Earnings from Operations (US$ in millions)
- Operational earnings increased from about $5.4 billion in 2005 to a peak of around $32.4 billion in 2023 before a slight decline to approximately $32.3 billion in 2024. Although earnings experienced some volatility during the 2007-2009 period, likely due to economic factors, the general trajectory is positive. The consistent rise from 2010 onward suggests improved operational efficiency and profitability, with the margin likely benefiting from the revenue increase.
- Net Earnings Attributable to UnitedHealth Group Common Shareholders (US$ in millions)
- Net earnings show a similar upward trend from approximately $3.3 billion in 2005 to a peak of around $22.4 billion in 2023. However, there is a notable drop in 2024 to roughly $14.4 billion. The period between 2014 and 2023 was marked by strong growth in net earnings, reflecting enhanced profitability and perhaps favorable market conditions. The sharp decline in 2024 warrants further examination, as it may indicate increased expenses, one-time charges, or changes in accounting treatments affecting net income.
- Overall Analysis
- The data indicates strong and sustained revenue growth over the examined period. Earnings from operations followed this positive trend, demonstrating successful conversion of revenues into operating profits. The net earnings growth through 2023 supports the notion of effective cost management and operational leverage, despite a recent decline in 2024. This pattern suggests robust financial health but also highlights potential challenges faced in the final year, which should be analyzed for underlying causes.
Balance Sheet: Assets
UnitedHealth Group Inc., selected items from assets, long-term trends
US$ in millions
| Current assets | Total assets | |
|---|---|---|
| Dec 31, 2024 | 85,779) | 298,278) |
| Dec 31, 2023 | 78,437) | 273,720) |
| Dec 31, 2022 | 69,069) | 245,705) |
| Dec 31, 2021 | 61,758) | 212,206) |
| Dec 31, 2020 | 53,718) | 197,289) |
| Dec 31, 2019 | 42,634) | 173,889) |
| Dec 31, 2018 | 38,692) | 152,221) |
| Dec 31, 2017 | 37,084) | 139,058) |
| Dec 31, 2016 | 33,879) | 122,810) |
| Dec 31, 2015 | 31,639) | 111,383) |
| Dec 31, 2014 | 23,556) | 86,382) |
| Dec 31, 2013 | 20,380) | 81,882) |
| Dec 31, 2012 | 21,052) | 80,885) |
| Dec 31, 2011 | 20,350) | 67,889) |
| Dec 31, 2010 | 18,393) | 63,063) |
| Dec 31, 2009 | 18,200) | 59,045) |
| Dec 31, 2008 | 14,990) | 55,815) |
| Dec 31, 2007 | 15,544) | 50,899) |
| Dec 31, 2006 | 16,044) | 48,320) |
| Dec 31, 2005 | 10,640) | 41,374) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
The analysis of the financial data over the period from 2005 to 2024 reveals clear growth trends in both current assets and total assets.
- Current Assets
- Current assets have shown a generally upward trajectory throughout the entire period. Starting at 10,640 million USD in 2005, current assets increased steadily with minor fluctuations, reaching 85,779 million USD by 2024. The data shows particularly notable growth after 2013, where the increase accelerated year-over-year, reflecting enhanced liquidity or an expansion in short-term assets. The growth from 2013 to 2024 is substantial, with current assets nearly quadrupling during this time frame. This suggests stronger operational capacity or accumulation of cash equivalents and marketable securities.
- Total Assets
- Total assets also exhibit robust growth over these two decades, increasing from 41,374 million USD in 2005 to 298,278 million USD in 2024. The increase is consistent, with the most pronounced growth observed after 2010, coinciding with accelerated expansion of current assets. Total assets more than septupled during the examined period. This indicates significant investment in long-term assets alongside current assets, possibly reflecting business expansion, acquisitions, or capital expenditures. The ratio of current assets to total assets suggests that while current assets have been increasing, a large portion of asset growth is likely attributed to long-term investments.
- Overall Trends and Insights
- The consistent increases in both current and total assets imply a strong growth strategy and efficient asset management. The faster growth in current assets relative to total assets in recent years could indicate a shift towards greater liquidity or short-term asset management. The absence of any major declines or volatility in the data points to stable financial performance and asset base expansion over the years analyzed.
Balance Sheet: Liabilities and Stockholders’ Equity
UnitedHealth Group Inc., selected items from liabilities and stockholders’ equity, long-term trends
US$ in millions
| Current liabilities | Total liabilities | Total debt | Shareholders’ equity attributable to UnitedHealth Group | |
|---|---|---|---|---|
| Dec 31, 2024 | 103,769) | 195,687) | 76,904) | 92,658) |
| Dec 31, 2023 | 99,054) | 174,801) | 62,537) | 88,756) |
| Dec 31, 2022 | 89,237) | 159,358) | 57,623) | 77,772) |
| Dec 31, 2021 | 78,292) | 135,727) | 46,003) | 71,760) |
| Dec 31, 2020 | 72,420) | 126,750) | 43,467) | 65,491) |
| Dec 31, 2019 | 61,782) | 11,727) | 40,678) | 57,616) |
| Dec 31, 2018 | 53,209) | 95,994) | 36,554) | 51,696) |
| Dec 31, 2017 | 50,463) | 87,036) | 31,692) | 47,776) |
| Dec 31, 2016 | 49,252) | 82,621) | 32,970) | 38,274) |
| Dec 31, 2015 | 42,898) | 75,922) | 32,094) | 33,830) |
| Dec 31, 2014 | 30,623) | 52,540) | 17,406) | 32,454) |
| Dec 31, 2013 | 27,881) | 48,558) | 16,860) | 32,149) |
| Dec 31, 2012 | 27,116) | 47,586) | 16,754) | 31,178) |
| Dec 31, 2011 | 23,922) | 39,597) | 11,638) | 28,292) |
| Dec 31, 2010 | 23,700) | 37,238) | 11,142) | 25,825) |
| Dec 31, 2009 | 22,163) | 35,439) | 11,173) | 23,606) |
| Dec 31, 2008 | 19,761) | 35,035) | 12,794) | 20,780) |
| Dec 31, 2007 | 18,492) | —) | 11,009) | 20,063) |
| Dec 31, 2006 | 18,497) | —) | 7,456) | 20,810) |
| Dec 31, 2005 | 16,644) | —) | 7,111) | 17,733) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
The financial data reveals several notable trends and patterns over the reported periods.
- Current Liabilities
- Current liabilities show a consistent upward trajectory from 2005 through 2024. Starting at approximately 16.6 billion US dollars in 2005, there is a steady increase each year, reaching around 103.8 billion US dollars by 2024. This indicates increasing short-term financial obligations, which may be reflective of expanded operations or growing financial activities.
- Total Liabilities
- Total liabilities are not reported for the years prior to 2008, but from 2008 onward, they display a clear growth trend. The figures move from about 35 billion US dollars in 2008 to nearly 196 billion US dollars in 2024. This significant rise shows a considerable increase in the overall obligations of the company, suggesting either substantial borrowing or increased liabilities connected to business expansion or acquisitions.
- Total Debt
- Total debt increases noticeably from 7.1 billion US dollars in 2005 to approximately 76.9 billion US dollars in 2024. There is a steady climb, with some periods of more rapid increases, for example, a sharp rise between 2013 and 2015 and continued increases thereafter. This pattern indicates that debt financing has been a key component of the company’s capital structure growth over the years.
- Shareholders’ Equity Attributable
- Shareholders' equity shows a consistent upward trend from 17.7 billion US dollars in 2005 to about 92.7 billion US dollars in 2024. The growth is relatively steady, reflecting accumulation of retained earnings and possibly capital infusions that increase the book value attributable to shareholders. This progressive increase in equity suggests that the company has been generating positive returns and reinvesting earnings.
Overall, the data reflects steady growth in both liabilities and equity, with liabilities—particularly total debt—increasing at a substantial pace. The rising level of current liabilities and total debt highlights a greater reliance on external financing sources. Meanwhile, the corresponding increase in shareholders' equity indicates strengthening financial solidity and retained profitability supporting the expansion of the company’s balance sheet over the years.
Cash Flow Statement
UnitedHealth Group Inc., selected items from cash flow statement, long-term trends
US$ in millions
| 12 months ended: | Cash flows from operating activities | Cash flows used for investing activities | Cash flows from (used for) financing activities |
|---|---|---|---|
| Dec 31, 2024 | 24,204) | (20,527) | (3,512) |
| Dec 31, 2023 | 29,068) | (15,574) | (11,529) |
| Dec 31, 2022 | 26,206) | (28,476) | 4,226) |
| Dec 31, 2021 | 22,343) | (10,372) | (7,455) |
| Dec 31, 2020 | 22,174) | (12,532) | (3,590) |
| Dec 31, 2019 | 18,463) | (12,699) | (5,625) |
| Dec 31, 2018 | 15,713) | (12,385) | (4,365) |
| Dec 31, 2017 | 13,596) | (8,599) | (3,441) |
| Dec 31, 2016 | 9,795) | (9,355) | (1,011) |
| Dec 31, 2015 | 9,740) | (18,395) | 12,239) |
| Dec 31, 2014 | 8,051) | (2,534) | (5,293) |
| Dec 31, 2013 | 6,991) | (3,089) | (4,946) |
| Dec 31, 2012 | 7,155) | (8,649) | 471) |
| Dec 31, 2011 | 6,968) | (4,172) | (2,490) |
| Dec 31, 2010 | 6,273) | (5,339) | (1,611) |
| Dec 31, 2009 | 5,625) | (976) | (2,275) |
| Dec 31, 2008 | 4,238) | (5,072) | (605) |
| Dec 31, 2007 | 5,877) | (4,147) | (3,185) |
| Dec 31, 2006 | 6,526) | (2,101) | 474) |
| Dec 31, 2005 | 4,326) | (3,489) | 593) |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
The analysis of cash flow activities over the given periods reveals several important trends and fluctuations.
- Cash Flows from Operating Activities
- This category exhibits a generally increasing trend over the years, starting at 4,326 million USD at the end of 2005 and reaching a peak of 29,068 million USD by the end of 2023. There are minor fluctuations, such as a slight decrease between 2006 and 2007, and some modest drops in later years, including 2024, which records a decrease to 24,204 million USD. Nonetheless, the overall upward trend suggests strengthening operational effectiveness and cash generation capabilities over the long term.
- Cash Flows Used for Investing Activities
- The investing activities show a predominantly negative cash flow, indicating ongoing capital expenditures, acquisitions, or other investments. The highest cash outflows occurred in 2015, with -18,395 million USD, and a significant peak again in 2022 at -28,476 million USD. While the figures fluctuate, the negative values throughout suggest continuous reinvestment into business assets or growth initiatives. Some years reflect lesser outflows, such as 2009 and 2014, but overall, the cash used for investing is substantial and exhibits considerable volatility especially in the later years.
- Cash Flows from (Used for) Financing Activities
- Financing cash flows present a more mixed and volatile pattern. Early years show relatively modest inflows and outflows, but from 2007 onward, there are substantial negative and positive swings. For instance, a major negative financing cash flow is recorded in 2013 (-4,946 million USD) and 2019 (-5,625 million USD), contrasted with a significant inflow in 2015 (12,239 million USD). The years 2022 and 2023 also show considerable volatility, with positive 4,226 million USD followed by negative -11,529 million USD. This pattern indicates active management of financial structure including debt issuance and repayments, share buybacks, or dividend payments with no clear sustained trend towards either net inflow or outflow.
In summary, operating cash flow demonstrates consistent growth indicative of improved core business performance. Investing cash flow confirms ongoing reinvestment efforts with notable variability in intensity. Financing cash flow swings reflect dynamic capital management strategies without a stable directional trend. Together, these patterns illustrate a company actively growing its operational base while engaging in significant investment and fluctuating financing activities to support its financial and strategic objectives.
Per Share Data
UnitedHealth Group Inc., selected data per share, long-term trends
US$
| 12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
|---|---|---|---|
| Dec 31, 2024 | 15.64 | 15.51 | 8.18 |
| Dec 31, 2023 | 24.12 | 23.86 | 7.29 |
| Dec 31, 2022 | 21.47 | 21.18 | 6.40 |
| Dec 31, 2021 | 18.33 | 18.08 | 5.60 |
| Dec 31, 2020 | 16.23 | 16.03 | 4.83 |
| Dec 31, 2019 | 14.55 | 14.33 | 4.14 |
| Dec 31, 2018 | 12.45 | 12.19 | 3.45 |
| Dec 31, 2017 | 10.95 | 10.72 | 2.88 |
| Dec 31, 2016 | 7.37 | 7.25 | 2.38 |
| Dec 31, 2015 | 6.10 | 6.01 | 1.88 |
| Dec 31, 2014 | 5.78 | 5.70 | 1.41 |
| Dec 31, 2013 | 5.59 | 5.50 | 1.05 |
| Dec 31, 2012 | 5.38 | 5.28 | 0.80 |
| Dec 31, 2011 | 4.81 | 4.73 | 0.61 |
| Dec 31, 2010 | 4.14 | 4.10 | 0.41 |
| Dec 31, 2009 | 3.27 | 3.24 | 0.03 |
| Dec 31, 2008 | 2.45 | 2.40 | 0.03 |
| Dec 31, 2007 | 3.55 | 3.42 | 0.03 |
| Dec 31, 2006 | 3.09 | 2.97 | 0.03 |
| Dec 31, 2005 | 2.61 | 2.48 | 0.02 |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1, 2, 3 Data adjusted for splits and stock dividends.
The financial data over the period from 2005 to 2024 reveals several noteworthy trends in the company's earnings and dividend performance.
- Basic Earnings Per Share (EPS)
- Basic EPS demonstrates a general upward trajectory, rising from $2.61 in 2005 to a peak of $24.12 in 2023. There was a minor dip in 2008 to $2.45, likely indicating a challenging financial period, but growth resumed consistently after that year. A notable decline occurs in the final year (2024), where EPS falls to $15.64, marking a significant reversal from the prior peak.
- Diluted Earnings Per Share (EPS)
- Diluted EPS trends closely mirror those of basic EPS, starting at $2.48 in 2005 and increasing to $23.86 by 2023. The dip in 2008 is also evident here. The subsequent rise remains steady and robust until the marked reduction to $15.51 in 2024. This parallel movement suggests consistent shareholder dilution effects over time.
- Dividends Per Share
- Dividend payments per share have shown a substantial increase throughout the observation period. Initial dividends were minimal and constant at $0.02-$0.03 from 2005 to 2009. A sudden and significant increase commenced in 2010 with a dividend of $0.41, followed by a steady upward trend peaking at $8.18 in 2024. This continuous rise reflects a strategic focus on returning greater value to shareholders via dividends.
In summary, the company exhibited strong earnings growth over nearly two decades, interrupted only briefly around 2008. The increased dividends correspond with improved earnings, underscoring a commitment to shareholder returns alongside financial growth. The abrupt earnings decline in 2024 warrants further investigation to understand its underlying causes and implications.